Entheon Biomedical Corp. (CSE:ENBI)

Canada flag Canada · Delayed Price · Currency is CAD
0.1000
0.00 (0.00%)
Aug 13, 2025, 1:28 PM EDT
11.11%
Market Cap 1.39M
Revenue (ttm) n/a
Net Income (ttm) -360.40K
Shares Out 13.86M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 5,000
Average Volume 12,442
Open 0.1000
Previous Close 0.1000
Day's Range 0.1000 - 0.1000
52-Week Range 0.0900 - 0.4500
Beta 1.57
RSI 47.67
Earnings Date Oct 24, 2025

About Entheon Biomedical

Entheon Biomedical Corp. operates as a biotechnology research and development company. The company develops products for treating addiction and substance use disorders. Entheon Biomedical Corp. is headquartered in Vancouver, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Timothy Ko
Employees 1
Stock Exchange Canadian Securities Exchange
Ticker Symbol ENBI
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.